Rhabdomyolysis during therapy with daptomycin.

66Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The use of daptomycin has been associated with an elevation in creatine phosphokinase level, with a reported incidence of 2.8% in phase III clinical trials. Published case reports have documented the presence of myopathy in patients who received daptomycin; however, there have been no previously reported cases of rhabdomyolysis in animals or humans to date. We describe a case of rhabdomyolysis during therapy with daptomycin.

Cite

CITATION STYLE

APA

Papadopoulos, S., Ball, A. M., Liewer, S. E., Martin, C. A., Winstead, P. S., & Murphy, B. S. (2006). Rhabdomyolysis during therapy with daptomycin. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 42(12). https://doi.org/10.1086/504379

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free